This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Precedo Pharmaceuticals Co., Ltd. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Husheng Mei: Innovator in Cell Culture Technology
Introduction
Husheng Mei is a notable inventor based in Anhui, China. He has made significant contributions to the field of biotechnology, particularly in the development of cell culture mediums for medical research.
Latest Patents
Husheng Mei holds a patent for a "Primary gastrointestinal stromal tumor cell culture medium, culture method and application thereof." This invention provides a specialized cell culture medium for culturing primary gastrointestinal stromal tumor cells. The medium comprises gastrin, N2, insulin, a receptor tyrosine kinase ligand, and a Rock kinase inhibitor. Additionally, the invention outlines a method for culturing gastrointestinal stromal tumor cells using this medium, along with applications for efficacy evaluation or screening of an expanded cell population obtained through this method.
Career Highlights
Husheng Mei is associated with Precedo Pharmaceuticals Co., Ltd., where he applies his expertise in cell culture technology. His work focuses on advancing research methodologies that can lead to better understanding and treatment of gastrointestinal stromal tumors.
Collaborations
Husheng Mei collaborates with colleagues such as Qingsong Liu and Feiyang Liu, contributing to a team effort in the field of biotechnology and medical research.
Conclusion
Husheng Mei's innovative work in cell culture technology represents a significant advancement in the study of gastrointestinal stromal tumors. His contributions are vital for future research and therapeutic applications in this area.